Discussing axSpA: Symptom duration impact on bimekizumab efficacy and therapeutic switching drivers
Join Dr Sofia Ramiro and Dr Atul Dheodhar as they…
March 19, 202633m 29s
Audio is streamed directly from the publisher (feeds.soundcloud.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Join Dr Sofia Ramiro and Dr Atul Dheodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered the impact of shorter versus longer symptom duration on the efficacy of bimekizumab and the factors associated with therapeutic switching in SpA.